The Dose-Dependent Effects of Spironolactone on TGF-β1 Expression and the Vulnerability to Atrial Fibrillation in Spontaneously Hypertensive Rats

The Dose-Dependent Effects of Spironolactone on TGF-β1 Expression and the Vulnerability to Atrial Fibrillation in Spontaneously Hypertensive Rats

Objective. This study tends to assess the dose-dependent effects of spironolactone on TGF-β1 expression, atrial fibrosis, and the vulnerability to atrial fibrillation in spontaneously hypertensive rats (SHRs) and tries to clarify the association of atrial fibrosis with the vulnerability to atrial fi...

Full description

Bibliographic Details
Main Authors:	Mirong Tang, Yan Chen, Fuqing Sun, Liangliang Yan
Format:	Article
Language:	English
Published:	Hindawi Limited 2021-01-01
Series:	Cardiology Research and Practice
Online Access:	http://dx.doi.org/10.1155/2021/9924381

Similar Items

Relationship between Atrial Fibrillation and Use of Spironolactone in Heart Failure Patients
by: Ke-Hsin Tsao, et al.
Published: (2009)

Novel role of spironolactone in the therapy of resistant hypertension: Spironolactone and resistant hypertension
by: Dragojević-Simić Viktorija, et al.
Published: (2019-01-01)

Pharmacotherapy of patients with atrial fibrillation and restored sinus rhythm – is the medication with spironolactone beneficial in this case?
by: Antoniya Kisheva, et al.
Published: (2021-04-01)

Detection of ST-2 and TGF-β2 levels in patients with atrial fibrillation and their correlation with atrial fibrillation remodeling
by: Xiang-Wen Hu, et al.
Published: (2021-07-01)

Effects of spironolactone in spontaneously hypertensive adult rats subjected to high salt intake
by: Marcelo Perim Baldo, et al.
Published: (2011-01-01)

Efficacy of low dose spironolactone in chronic kidney disease with resistant hypertension
by: Rozita Abolghasmi, et al.
Published: (2011-01-01)

Spironolactone to improve exercise tolerance in people with permanent atrial fibrillation and preserved ejection fraction: the IMPRESS-AF RCT
by: Eduard Shantsila, et al.
Published: (2020-07-01)

Role of the MAPKs/TGF-β1/TRAF6 signaling pathway in postoperative atrial fibrillation.
by: Daoliang Zhang, et al.
Published: (2017-01-01)

Apelin Inhibits Angiotensin II-Induced Atrial Fibrosis and Atrial Fibrillation via TGF-β1/Smad2/α-SMA Pathway
by: Wenkui Lv, et al.
Published: (2020-11-01)

Aerobic Interval Training Prevents Age-Dependent Vulnerability to Atrial Fibrillation in Rodents
by: Vegard Malmo, et al.
Published: (2018-03-01)

LncRNA PVT1 regulates atrial fibrosis via miR-128-3p-SP1-TGF-β1-Smad axis in atrial fibrillation
by: Feng Cao, et al.
Published: (2019-03-01)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
by: Ivan Velat, et al.
Published: (2020-08-01)

Different spontaneous breathing trials in patients with atrial fibrillation
by: J.B. Blanco, et al.
Published: (2016-03-01)

Different Spontaneous Breathing Trials in Patients with Atrial Fibrillation
by: Yen-Han Tseng, et al.
Published: (2015)

Early Spironolactone Treatment Attenuates Heart Failure Development by Improving Myocardial Function and Reducing Fibrosis in Spontaneously Hypertensive Rats
by: Marcelo D.M. Cezar, et al.
Published: (2015-07-01)

The feasibility and correlation of atrial fibrillation vulnerability test to the indices of atrial substrates using atrial burst decremental pacing
by: Wei-Hua Tang, et al.
Published: (2013-06-01)

INFLUENCE OF AEROBIC AND RESISTANT LOAD ON THE RISK OF ATRIAL FIBRILLATION IN ARTERIAL HYPERTENSION AND PAROXYSMAL ATRIAL FIBRILLATION
by: K. G. Adamyan, et al.
Published: (2015-10-01)

Atrial fibrillation in the patients with obesity and arterial hypertension
by: N. S. Tsyplenkova, et al.
Published: (2015-10-01)

Upregulation of Transient Receptor Potential Canonical Type 3 Channel via AT1R/TGF-β1/Smad2/3 Induces Atrial Fibrosis in Aging and Spontaneously Hypertensive Rats
by: Rongfang He, et al.
Published: (2019-01-01)

Role of spironolactone in patients with resistant hypertension: A narrative review
by: Geeta Sheth, et al.
Published: (2021-01-01)

Predictors of spontaneous echo contrast and left atrial appendage thrombosis in nonvalvular atrial fibrillation
by: N. Yu. Khorkova, et al.
Published: (2020-08-01)

NOX4-dependent Hydrogen Peroxide Overproduction in Human Atrial Fibrillation and HL-1 Atrial Cells: Relationship to Hypertension
by: Jun eZhang, et al.
Published: (2012-06-01)

The potential regulatory role of hsa_circ_0004104 in the persistency of atrial fibrillation by promoting cardiac fibrosis via TGF-β pathway
by: Yuanfeng Gao, et al.
Published: (2021-01-01)

TGFβ Is Specifically Upregulated on Circulating CD14++ CD16+ and CD14+ CD16++ Monocytes in Patients with Atrial Fibrillation and Severe Atrial Fibrosis
by: David Heinzmann, et al.
Published: (2018-08-01)

Atrial Cardiomyopathy and Atrial Fibrillation in Cancer
by: Mengdi Ren, et al.
Published: (2021-01-01)

SPECIAL CONSIDERATIONS REGARDING WARFARIN DOSE TITRATION IN PATIENTS WITH ATRIAL FIBRILLATION DEPENDING ON CLINICAL FACTORS
by: E. L. Artanova, et al.
Published: (2016-01-01)

Modern warfarin- dosing algorithms in patients with atrial fibrillation
by: M. Yu. Kolesnyk, et al.
Published: (2015-12-01)

Predictors of progression of atrial fibrillation in patients with arterial hypertension
by: V I Podzolkov, et al.
Published: (2016-03-01)

Clinical impact of atrial fibrillation in patients with pulmonary hypertension.
by: Dennis Rottlaender, et al.
Published: (2012-01-01)

Predictors of progression of atrial fibrillation in patients with arterial hypertension
by: Podzolkov V.I., et al.
Published: (2016-01-01)

Arterial hypertension in combination with atrial fibrillation and extracardiac diseases
by: L D Khidirova, et al.
Published: (2018-12-01)

Hypertension and atrial fibrillation: Closing a virtuous circle.
by: Ying X Gue, et al.
Published: (2021-06-01)

Spironolactone in pulmonary arterial hypertension: results of a cross-over study
by: Zeenat Safdar, et al.
Published: (2020-04-01)

Diuretic Effect of Prosopis farcta in Comparison with Spironolactone and Hydrochlorothiazide in Hypertensive Rats
by: Zana M.Raoof, et al.
Published: (2020-06-01)

The Effect of Spironolactone on Control of Pulmonary Hypertension in Patients with Obstructive Pulmonary Disease
by: Mohammad Emami, et al.
Published: (2019-01-01)

Association between transforming growth factor β1 polymorphisms and atrial fibrillation in essential hypertensive subjects
by: Li Yuliang, et al.
Published: (2010-03-01)

A functional polymorphism C-509T in TGFβ-1 promoter contributes to susceptibility and prognosis of lone atrial fibrillation in Chinese population.
by: Hailong Cao, et al.
Published: (2014-01-01)

Reply to the Letter: Different spontaneous breathing trials in patients with atrial fibrillation
by: Y.-H. Tseng, et al.
Published: (2016-03-01)

Targeting TGFβR2‐mutant tumors exposes vulnerabilities to stromal TGFβ blockade in pancreatic cancer
by: Huocong Huang, et al.
Published: (2019-11-01)

Spontaneous atrial fibrillation after long-term transesophageal atrial burst pacing in rats. Technical and procedural approach to a new in vivo atrial fibrillation model
by: Scridon Alina, et al.
Published: (2018-01-01)

Cannot write session to /tmp/vufind_sessions/sess_d9bc6oked93pvs46r6chp9dfl1